PeLeMed

About:

PeLeMed is a drug development company working on the discovery of anti-cancer drugs.

Top Investors: Spring Camp, KDB Capital, SGI Venture Capital, Daekyo Investment, Dt& Investment

Description:

PeLeMed is a drug development company working on the discovery of anti-cancer drugs. The company's innovative therapeutic candidates through type 1 kinase inhibitor development platform.

Total Funding Amount:

6.5B KRW

Headquarters Location:

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Founded Date:

2020-01-01

Founders:

Yong Chul Kim

Number of Employees:

11-50

Last Funding Date:

2020-12-01

IPO Status:

Private

Industries: